Clinical trial
Effects of Ranibizumab on Microvasculature, Oxidative Stress and Recurrence in Primary Pterygium Surgery
NCT04878835 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Ranibizumab on Microvasculature, Oxidative Stress and Recurrence in Primary Pterygium Surgery
- Lead sponsor
- Universiti Sains Malaysia
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 1, 2018
- Completion date
- April 30, 2020
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patients with primary nasal pterygium